31/10/2014 00:07:55 Free Membership Login

Merck News (NYSE:MRK)

DateTimeSource
Headline
10/27/20144:37PMDJNMARKET SNAPSHOT: Energy Stocks Sap S&P 500
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market bounced between gains and losses before wrapping up Monday's relatively benign trading session mostly unchanged. The S&P 500 (SPX) closed 3 points, or 0.2%, lower at 1,961.63, with energy and materials dragging down... More...>>
10/27/20142:06PMDJNMARKET SNAPSHOT: U.S. Stocks Retreat; Energy Stocks Sell Off
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks dipped in and out of negative territory on Monday, as investors flocked to stocks of large, dividend-paying companies over shares of those businesses tethered to the strength of the overall economy. Gains in shares of so-called... More...>>
10/27/20141:57PMDJNMARKET SNAPSHOT: U.S. Stocks Retreat; Energy Stocks Sell Off
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks dipped in and out of negative territory on Monday, as investors flocked to stocks of large, dividend-paying companies over shares of firms whose businesses are tethered to the strength of the overall economy and can be prone to... More...>>
10/27/201411:52AMDJNMARKET SNAPSHOT: U.S. Stocks Retreat; Energy Stocks Sell Off
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks retreated on Monday, pausing after a big rally last week, as big losses in the energy and materials sector weighed on the main benchmark. Crude oil prices plummeted after Goldman Sachs analysts slashed their target price to $75... More...>>
10/27/201411:51AMDJNMARKET SNAPSHOT: U.S. Stocks Retreat; Energy Stocks Sell Off
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks retreated on Monday, pausing after a big rally last week, as big losses in the energy and materials sector weighed on the main benchmark. Crude oil prices plummeted after Goldman Sachs analysts slashed their target price to $75... More...>>
10/27/201411:51AMDJNMARKET SNAPSHOT: U.S. Stock Retreat; Energy Stocks Sell Off
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks retreated on Monday, pausing after a big rally last week, as big losses in the energy and materials sector weighed on the main benchmark. Crude oil prices plummeted after Goldman Sachs analysts slashed their target price to $75... More...>>
10/27/201411:47AMDJNMARKET SNAPSHOT: U.S. Stock: Futures Fall; Focus On Fed
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- U.S. stock futures fell on Monday, indicating a lower open on Wall Street, as investors paused after a big rally last week. Across the Atlantic relatively sanguine results of a series of tests of the health of the European banking system were... More...>>
10/27/201411:40AMDJNMARKET SNAPSHOT: Stock Futures Flatten After Weak German Data; Focus On Fed
By Barbara Kollmeyer, MarketWatch MADRID (MarketWatch) -- U.S. stock futures struggled to move higher Monday, as relief from the relatively sanguine results of a series of tests of the health of the European banking system were overshadowed by worry over weak German data. More data likely will dictate Monday's sentiment... More...>>
10/27/201411:28AMDJNMARKET SNAPSHOT: Stock Futures Flatten After Weak German Data; Focus On Fed
By Barbara Kollmeyer, MarketWatch MADRID (MarketWatch) -- U.S. stock futures struggling Monday as relief after European Union bank stress tests was replaced by worry over weak German data. Analysts said investors could see some jitters in the run-up to this week's Federal Open Market Committee meeting. Futures for the... More...>>
10/27/20147:00AMBWMerck Announces Third-Quarter 2014 Financial Results
Third-Quarter 2014 Non-GAAP EPS of $0.90, Excluding Certain Items, and GAAP EPS of $0.31 Narrows 2014 Full-Year Non-GAAP EPS Target to $3.46 to $3.50, Excluding Certain Items; Updates 2014 Full-Year GAAP EPS Target to $4.06 to $4.29; Now Expects 2014 Full-Year Revenues to be Between $42.4 Billion and $42.8 Billion Generated... More...>>
10/27/20146:45AMBWMerck Receives FDA Breakthrough Therapy Designation for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, for the treatment of patients with Epidermal Growth Factor Receptor (EGFR... More...>>
10/26/20145:18AMDJNMARKET SNAPSHOT: Energy, Health Care Earnings To Dominate Week
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch)--Earnings from the energy and health care sectors will dominate investor attention as respective heavyweights report following a week where upside earnings surprises lifted the broader market out of a slump. The broader market comes off a big week with the Dow... More...>>
10/20/20148:00AMBWUS FDA Accepts for Review a Biologics License Application for Merck & Sanofi Pasteur’s Investigational Pediatric Hexavalent...
Phase III clinical study data presented at IDWeek in Philadelphia Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT:SAN and NYSE:SNY), announced today that the Biologics License Application (BLA) filed for the companies’ investigational... More...>>
10/20/20148:00AMPRNUSAward-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals
Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals Merkerson Visits Atlanta, Georgia on October 20 With America's Diabetes Challenge: Get to Your Goals Program PR Newswire WHITEHOUSE STATION, N.J., Oct. 20, 2014 WHITEHOUSE STATION, N.J., Oct. 20, 2014... More...>>
10/15/20148:00AMBWMerck Announces Final Results of Tender Offers for Eight Series of Notes
Merck & Co., Inc. (“Merck”) (NYSE:MRK), known as MSD outside the United States and Canada, announced today the final results of the previously announced offers to purchase (collectively, the “Offers”) any and all of the outstanding notes listed in the table below (collectively, the “Notes”). On Oct. 6... More...>>
10/14/20146:20PMBWMerck Announces Pricing of Tender Offers for Eight Series of Notes
Merck & Co., Inc. (“Merck”) (NYSE:MRK), known as MSD outside the United States and Canada, announced today the pricing of the previously announced offers to purchase (collectively, the “Offers”) any and all of the outstanding notes listed below (collectively, the “Notes”). The Offers are being made upon... More...>>
10/08/201411:13AMBWMerck to Present New Data from Clinical Studies Evaluating Investigational Hepatitis C Treatment Grazoprevir/Elbasvir (MK-517...
Interim results of C-SWIFT, a Phase 2 study evaluating ultra-short treatment durations of grazoprevir/elbasvir (MK-5172/MK-8742) plus sofosbuvir, to be presented Results from the C-WORTHy study, a Phase 2 clinical trial evaluating grazoprevir/elbasvir (MK-5172/MK-8742) across multiple patient populations, including difficult-to-cure... More...>>
10/06/201412:28PMBWMerck Prices EUR 2.5 Billion Debt Offering
Merck & Co., Inc. (the “Company”) (NYSE:MRK), known as MSD outside of the United States and Canada, priced today EUR 2.5 billion public offering of three series of Euro-denominated senior unsecured notes (collectively, the “New Notes”). Based on Oct. 3, 2014, closing exchange rates the EUR 2.5 billion equates... More...>>
10/06/20143:24AMBWMerck Announces Proposed Public Debt Offering
Merck & Co., Inc. (the “Company”) (NYSE:MRK), known as MSD outside the United States and Canada, announced today the commencement of a public offering of three series of Euro denominated senior unsecured notes due 2021, 2026 and 2034 (collectively, the “New Notes”). The exact terms and timing of the offering... More...>>
10/06/20143:18AMBWMerck Announces Tender Offers for Eight Series of Notes
Merck & Co., Inc. (“Merck”) (NYSE:MRK), known as MSD outside the United States and Canada, announced today the commencement of offers to purchase (collectively, the “Offers”) any and all of the outstanding notes listed below (collectively, the “Notes”). The Offers are being made upon, and are subject to... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nyse mrk141031 00:07